Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan <scp>COVID</scp> ‐19 task force-Reference-Cited by-同舟云学术

Clinical significance of prediabetes, undiagnosed diabetes and diagnosed diabetes on critical outcomes in COVID‐19: Integrative analysis from the Japan COVID ‐19 task force

Published:2022-09-26 Issue:1 Volume:25 Page:144-155
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Fukushima Takahiro¹,Chubachi Shotaro¹^ORCID,Namkoong Ho¹²,Asakura Takanori¹³⁴,Tanaka Hiromu¹,Lee Ho¹,Azekawa Shuhei¹,Okada Yukinori⁵⁶⁷,Koike Ryuji⁸,Kimura Akinori⁹,Imoto Seiya¹⁰,Miyano Satoru¹¹,Ogawa Seishi¹²¹³,Kanai Takanori¹⁴,Fukunaga Koichi¹,

Affiliation:

1. Division of Pulmonary Medicine, Department of Medicine Keio University School of Medicine Tokyo Japan

2. Department of Infectious Diseases Keio University School of Medicine Tokyo Japan

3. Department of Clinical Medicine (Laboratory of Bioregulatory Medicine) Kitasato University School of Pharmacy Tokyo Japan

4. Department of Respiratory Medicine Kitasato University Kitasato Institute Hospital Tokyo Japan

5. Department of Statistical Genetics Osaka University Graduate School of Medicine Suita Japan

6. Department of Genome Informatics Graduate School of Medicine, The University of Tokyo Tokyo Japan

7. Laboratory for Systems Genetics RIKEN Center for Integrative Medical Sciences Yokohama Japan

8. Medical Innovation Promotion Center Tokyo Medical and Dental University Tokyo Japan

9. Institute of Research Tokyo Medical and Dental University Tokyo Japan

10. Division of Health Medical Intelligence Human Genome Center, The Institute of Medical Science, The University of Tokyo Tokyo Japan

11. M&D Data Science Center Tokyo Medical and Dental University Tokyo Japan

12. Department of Pathology and Tumor Biology Institute for the Advanced Study of Human Biology (WPI‐ASHBi), Kyoto University Kyoto Japan

13. Department of Medicine, Center for Hematology and Regenerative Medicine Karolinska Institute Stockholm Sweden

14. Division of Gastroenterology and Hepatology, Department of Medicine Keio University School of Medicine Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Health, Labour and Welfare

Mitsubishi Foundation

Takeda Science Foundation

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14857

Reference37 articles.

1. Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis

2. Influence of diabetes mellitus on the severity and fatality of SARS‐CoV‐2 (COVID‐19) infection

3. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan

4. International Diabetes Federation (IDF).Diabetes Atlas 2021.https://diabetesatlas.org/.

5. Haemoglobin A1c is a predictor of COVID‐19 severity in patients with diabetes

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gastrointestinal symptoms in COVID-19 and disease severity: a Japanese registry-based retrospective cohort study;Journal of Gastroenterology;2024-01-25

2. Epicardial adipose tissue measured from analysis of adipose tissue area using chest CT imaging is the best potential predictor of COVID-19 severity;Metabolism;2024-01

3. Comparison of Azvudine and Nirmatrelvir/Ritonavir and Combined Use in Patients with COVID-19;Infection and Drug Resistance;2023-12

4. Application of natural compounds in the treatment and prevention of prediabetes;Frontiers in Nutrition;2023-11-30

5. Prognostic significance of hypertension history and blood pressure on admission in Japanese patients with coronavirus disease 2019: integrative analysis from the Japan COVID-19 Task Force;Hypertension Research;2023-11-02